Weil Company’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-2,899
| Closed | -$219K | – | 116 |
|
|
2025
Q3 | $219K | Sell |
2,899
-5
| -0.2% | -$343 | 0.05% | 113 |
|
|
2025
Q2 | $200K | Buy |
+2,904
| New | +$190K | 0.05% | 114 |
|
|
2024
Q4 | – | Sell |
-5,091
| Closed | -$320K | – | 113 |
|
|
2024
Q3 | $320K | Hold |
5,091
| – | – | 0.1% | 125 |
|
|
2024
Q2 | $301K | Hold |
5,091
| – | – | 0.11% | 124 |
|
|
2024
Q1 | $406K | Sell |
5,091
-2,396
| -32% | -$183K | 0.16% | 103 |
|
|
2023
Q4 | $591K | Sell |
7,487
-5,578
| -43% | -$397K | 0.26% | 70 |
|
|
2023
Q3 | $912K | Sell |
13,065
-4,851
| -27% | -$344K | 0.45% | 47 |
|
|
2023
Q2 | $1.24M | Sell |
17,916
-5,886
| -25% | -$419K | 0.55% | 47 |
|
|
2023
Q1 | $1.77M | Sell |
23,802
-15,729
| -40% | -$1.32M | 0.8% | 35 |
|
|
2022
Q4 | $3.68M | Sell |
39,531
-19,486
| -33% | -$1.88M | 1.68% | 14 |
|
|
2022
Q3 | $5.63M | Buy |
59,017
+5,232
| +10% | +$518K | 3.46% | 4 |
|
|
2022
Q2 | $4.98M | Sell |
53,785
-37
| -0.1% | -$3.61K | 2.8% | 6 |
|
|
2022
Q1 | $5.45M | Sell |
53,822
-5,362
| -9% | -$563K | 2.74% | 6 |
|
|
2021
Q4 | $6.11M | Sell |
59,184
-1,265
| -2% | -$117K | 2.85% | 4 |
|
|
2021
Q3 | $5.13M | Buy |
60,449
+41
| +0.1% | +$3.43K | 2.67% | 6 |
|
|
2021
Q2 | $5.04M | Buy |
60,408
+11,627
| +24% | +$952K | 2.55% | 8 |
|
|
2021
Q1 | $3.67M | Sell |
48,781
-2,670
| -5% | -$194K | 2.08% | 8 |
|
|
2020
Q4 | $3.51M | Buy |
51,451
+4,452
| +9% | +$290K | 2.1% | 9 |
|
|
2020
Q3 | $2.75M | Buy |
46,999
+6,025
| +15% | +$375K | 2% | 10 |
|
|
2020
Q2 | $2.66M | Sell |
40,974
-925
| -2% | -$58.2K | 2.25% | 9 |
|
|
2020
Q1 | $2.49M | Buy |
41,899
+2,702
| +7% | +$180K | 2.34% | 10 |
|
|
2019
Q4 | $2.91M | Buy |
39,197
+815
| +2% | +$57.2K | 2.22% | 9 |
|
|
2019
Q3 | $2.42M | Buy |
38,382
+6,953
| +22% | +$412K | 1.8% | 10 |
|
|
2019
Q2 | $1.71M | Sell |
31,429
-7,213
| -19% | -$388K | 1.39% | 18 |
|
|
2019
Q1 | $2.08M | Sell |
38,642
-2,538
| -6% | -$157K | 1.74% | 13 |
|
|
2018
Q4 | $2.7M | Buy |
41,180
+16,200
| +65% | +$1.21M | 2.44% | 10 |
|
|
2018
Q3 | $1.83M | Buy |
24,980
+7,436
| +42% | +$532K | 1.51% | 19 |
|
|
2018
Q2 | $1.13M | Buy |
+17,544
| New | +$1.16M | 0.95% | 30 |
|
Other funds holding CVS
Weil Company's CVS Position: Q4 2025 in Review
Weil Company sold out of CVS Health (CVS) in Q4 2025, closing a stake of 2,899 shares — an estimated $219K sold.
Weil Company first reported a position in CVS in Q2 2018 and held it in 28 quarters. The position peaked at $6.11M in Q4 2021. 1,948 funds tracked by Wall St. Rank hold CVS as of Q4 2025.
- Weil Company reported no remaining CVS Health position as of Q4 2025 after selling out during the quarter.
- Weil Company sold 2,899 CVS Health shares in Q4 2025, an estimated $219K.
- Weil Company first reported a position in CVS Health in Q2 2018 and held it in 28 quarters.
- Weil Company's CVS Health position peaked at $6.11M in Q4 2021.
- 1,948 funds tracked by Wall St. Rank held CVS Health as of Q4 2025.
Based on Weil Company's 13F filing for Q4 2025, filed 14 Jan 2026.